ADAMTS13 and thrombotic thrombocytopenic purpura: As early recognition of TTP and prompt therapeutic intervention are critical to patient outcomes, blood for ADAMTS13 testing should be drawn prior to the first plasma exchange treatment, but diagnosis for TTP can still occur after plasma exchange therapy has been initiated [19, 20].